The U. S. Food and Drug Administration (FDA) has recently announced that it may use blockchain technology in the future. According to the organization, this technology could be used to improve medical product reviews and recalls.
Amy Abernethy, deputy commissioner of the institution, has affirmed that the main goal of the organization with the technology to modernize the way that healthcare is able to communicate with other important agencies.
According to her, the organization will use blockchain, artificial intelligence (AI) and APIs to create a fully interoperable system that will handle the way that information is shared and medicine is reviewed.
Abernethy affirmed that this will make the agency much more agile and efficient and that new traceability solutions will certainly allow it to crosscheck information better and to guarantee that the quality of data will be solid.
With blockchain technology, a system in which information is sent quickly and can receive feedback in real-time may be possible. The whole process of approving a medicine will become quite faster this way and less paperwork will be needed as blockchain is an immutable ledger that can easily store all the information.
Another way in which technology can be used is to improve the quality of medical surveillance and to determine when to recall medicine. The system will let recalls happen faster and with fewer problems, it was affirmed. Also, medicine will possibly become more targeted and individual with the aid of these solutions.
The new system is expected to be launched in around a month or two, according to the deputy commissioner.
Like what you read? Give us one like or share it to your friends